Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carla Greenbaum
Benaroya Research Institute at Virginia Mason: Diabetes Research Program
Study Chair - Jane Buckner, M.D.
Benaroya Research Institute at Virginia Mason: Diabetes Research Program
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Children'S Hospital at Westmead: Kids Research Institute
Westmead, New South Wales, Australia
- Lady Cilento Children'S Hospital: Department of Endocrinology
South Brisbane, Queensland, Australia
- University of California San Francisco
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- Yale University School of Medicine: Diabetes Endocrinology Research Center
New Haven, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- University of Miami: Diabetes Research Institute
Miami, Florida, United States
- University of South Florida: Diabetes Center
Tampa, Florida, United States
- Indiana University Health - Riley Hospital for Children
Indianapolis, Indiana, United States
- University of Iowa
Iowa City, Iowa, United States
- Harvard University, Joslin Diabetes Center
Boston, Massachusetts, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- Columbia University, Naomi Berrie Diabetes Center
New York, New York, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Sanford Research
Sioux Falls, South Dakota, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Benaroya Research Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Mar 2015
- Primary completion
- 10 Jul 2019
- Completion
- 31 Aug 2020
- Last update posted
- 8 Sept 2021
- Registered enrollment
- 136
- Registry id
- NCT02293837
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.